Draft:Anand Reddi

From WikiProjectMed
Jump to navigation Jump to search


Anand Reddi is a health system strengthening policy expert and global health advocate known for his scholarly and advocacy work on global HIV scale-up including the President's Emergency Plan for AIDS Relief (PEPFAR).[1][2][3][4][5][6]. Currently, he works in the biotech industry advancing global access to medicines and building public-private health partnerships.[7][8][9]. He previously was on the global health not-for-profit board of directors of the AIDS Healthcare Foundation and the Bay Area Global Health Alliance.[10]

Early Life and Education

Reddi was born in Maryland, USA. He pursued his undergraduate studies at the University of Michigan, Ann Arbor.[11] In 2005, he was a Fulbright Scholar to KwaZulu-Natal, South Africa, focusing on pediatric antiretroviral scale-up under the mentorship of Hoosen Coovadia at the PEPFAR funded Sinikithemba HIV/AIDS clinic at McCord Hospital.[12] Reddi pursued a medical degree at the University of Colorado School of Medicine.[13]

Global Health Research

In the early 2000s it was uncertain if the provision of antiretroviral therapy in resource limited settings such as Southern Africa was feasible.[14] Reddi's research demonstrated that pediatric antiretroviral therapy is effective despite the challenges of a resource limited setting.[15] These data were important in providing supporting implementation experience to HIV scale-up initiatives by PEPFAR and The Global Fund.[16] His scholarly work has appeared in AIDS, Journal of Acquired Immune Deficiency Syndromes and Science. He also has written opinion pieces in The Huffington Post, The New York Times and The Washington Post on global health and U.S. domestic healthcare issues.[17][18]

Reddi's advocacy brought attention to the flatlining of global AIDS funding by U.S. President Barack Obama's administration in 2010.[19][20][21][22] Within six hours, Ezekiel Emanuel, President Obama's senior adviser for Health Policy, responded directly to Reddi by writing in The Huffington Post: "Contrary to what Dr. Reddi argues, neither I nor the Obama Administration sees an "either-or" trade-off between PEPFAR and other global health priorities such as improving maternal-child health".[23] Reddi rebutted Emanuel's op-ed with a follow-up op-ed that resulted in the restoration of $366 million for antiretroviral scale-up in Uganda.[24]

In 2011, the AIDS Healthcare Foundation (AHF) launched a campaign against the Food and Drug Administration review of Truvada for use as a HIV Pre-exposure Prophylaxis (PrEP) drug.[25] Reddi resigned from the Board of Directors of AHF over their opposition to HIV PrEP writing: "AHF’s media campaign against FDA review of PrEP is myopic, blinded by its determination to derail a promising new medication."[26] In 2015, the World Health Organization recommended that people at substantial risk of HIV infection should be offered tenofovir disoproxil fumarate (TDF)-based oral PrEP as an additional HIV prevention option.[27]

To address the shortage of healthcare workers in resource limited settings such as Southern Africa, Reddi proposed the utilization of human capital contracts for global health building on the work of the Noble Prize in Economic Sciences winner Milton Friedman.[28][29] The Reddi idea proposed is that an investor, such as a donor nation, charitable foundation like the Gates Foundation, or global health initiative, will cover the entire cost of a student's medical training. In exchange, the student will work for the first 10 years of their medical career in a government or NGO sponsored health clinic in their respective country of medical education. Their medical license will be contingent on this obligatory national service. Additionally, a multilateral “binding” agreement between the African country and destination countries (such as Australia, Canada, New Zealand, United Kingdom, and the United States)-brokered by the investor- could prevent migration during the term period to mitigate the potential for "brain-drain".[30]

At Gilead Sciences, Reddi spearheaded one of the largest HIV Test & Treat projects in collaboration with The Vatican in Shinyanga, Tanzania.[31][32] The public private partnership between the biotech industry, the Vatican, Tanzanian government and HIV/AIDS NGOs such as Doctors with Africa CUAMM and Joep Lange's Amsterdam Institute of Global Health and Development pioneered a decentralized HIV test & treat outreach campaign to find at-risk populations, ultimately testing over 300,000 people and linking those HIV-positive to treatment.[33] Outcomes from the Tanzania Test & Treat project between May 2017 and June 2019 were 255,329 HIV tests performed and the overall HIV positivity rate was 1.2%.[34]

References

  1. ^ Purvis, Katherine. "How do we increase the HIV response with limited funds?". The Guardian. Retrieved 6 July 2024.
  2. ^ Banning-Lover, Rachel. "What is the best model to bring healthcare to all?". The Guardian. Retrieved 19 June 2024.
  3. ^ "AD Talks 2020: Health Capacities as a New Power Instrument". Atlantic Dialogues. Retrieved 19 June 2024.
  4. ^ Mungcal, Ivy (18 October 2011). "Anand Reddi: PEPFAR at Risk Should Mitt Romney Become US President". Devex.
  5. ^ "Global Health Service Corps Essential To Improve African Health Systems, Achieve 'AIDS-Free Generation'". Kaiser Family Foundation.
  6. ^ Judem, Emily. "An invisible issue: The presidential campaign and HIV/AIDS". The World Radio Program.
  7. ^ Bulik, Beth Snyder (28 Oct 2020). "BI, Gilead execs highlight value of disease awareness campaigns—particularly during the pandemic". Fierce Pharma.
  8. ^ "Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advances Toward Global Phase 3 Trials". The Globe and Mail. 30 March 2021.
  9. ^ "Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati". NASDAQ. 28 June 2022.
  10. ^ "Speaking out on Social/Political issues: CHRO's role in working with CEO". HR Strategy Forum. Retrieved 8 July 2024.
  11. ^ "Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934". UNITED STATES SECURITIES AND EXCHANGE COMMISSION.
  12. ^ "Michigan News". Michigan Today.
  13. ^ "Achievements in academics, service recognized with CU's 2013 Jefferson Award". University of Colorado. Retrieved 7 July 2024.
  14. ^ Herbert, Bob (11 June 2001). "In America; Refusing To Save Africans". The New York Times.
  15. ^ Reddi, Anand; Leeper, Sarah C.; Grobler, Anneke C.; Geddes, Rosemary; France, K Holly; Dorse, Gillian L.; Vlok, Willem J.; Mntambo, Mbali; Thomas, Monty; Nixon, Kristy; Holst, Helga L.; Karim, Quarraisha Abdool; Rollins, Nigel C.; Coovadia, Hoosen M.; Giddy, Janet (17 March 2017). "Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa". BMC Pediatrics. 7 (12): 13. doi:10.1186/1471-2431-7-13. PMC 1847430. PMID 17367540.
  16. ^ Leeper, Sarah C; Reddi, Anand (2010-09-10). "United States global health policy: HIV/AIDS, maternal and child health, and The President's Emergency Plan for AIDS Relief (PEPFAR)". AIDS. 24 (14): 2145–2149. doi:10.1097/QAD.0b013e32833cbb41. ISSN 0269-9370.
  17. ^ "U.S. Global Health Policy: HIV/AIDS at a Crossroads Initial Accomplishments Threatened by Policy Changes". University of Colorado School of Medicine. CU Medicine Today. Retrieved 6 July 2024.
  18. ^ "Contributor:Anand Reddi". The Huffington Post. Retrieved 19 June 2024.
  19. ^ D'Almeida, Kanya. "Obama AIDS Plan Stumbles over Funding". Global Issues. Inter Press Service. Retrieved 19 June 2024.
  20. ^ Reddi, Anand (21 June 2010). "United States Global Health Policy: HIV/AIDS Treatment Funding At Risk Under President Obama". The Huffington Post.
  21. ^ Khan, Azmat (19 July 2012). "What Is President Obama's Track Record on HIV/AIDS?". Frontline (PBS).
  22. ^ Mungcal, Ivy (22 July 2010). "Eric Goosby, Bill Clinton Defend Obama's AIDS Funding Decisions". Devex.
  23. ^ Emanuel, Ezekiel J (21 July 2010). "The HIV/AIDS Fight Needs Cooperation, Not Division". The Huffington Post.
  24. ^ Mungcal, Ivy (23 July 2010). "Obama Promises to Step Up AIDS Fight". Devex.
  25. ^ "AHF to Gilead: "No Magic Pill" Ads Warn against AIDS Drug as HIV Prevention". AIDS Healthcare Foundation. 9 March 2011.
  26. ^ "Moving Forward on FDA Review of HIV Prevention Drugs". The Huffington Post. 2 Nov 2011.
  27. ^ World Health Organization. "Pre-exposure prophylaxis (PrEP)". Global HIV Program: PrEP. Retrieved 12 June 2024.
  28. ^ Reddi, Anand; Thyssen, Andreas. "Healthcare Reform: Solving the Medical Student Debt Crisis Through Human Capital Contracts". The Huffington Post.
  29. ^ Weinstein, Louis; Wolfe, Honor (1 July 2010). "A unique solution to solve the pending medical school tuition crisis". American Journal of Obstetrics and Gynecology. 203 (1): 19.e1–19.e3. doi:10.1016/j.ajog.2009.11.019. PMID 20035918.
  30. ^ Reddi, A.; Thyssen, A.; Smith, D.; Lange, J. H.; Akileswaran, C. (2012). "Human capital contracts for global health: a plan to increase the number of physicians in resource limited settings". AIDS. 26 (15): 1979–1980. doi:10.1097/QAD.0b013e32835857d4. PMID 22992581.
  31. ^ Tanzania, World Health Organization. "The Tanzania Catholic Church launches the Test and Treat Project". WHO Tanzania. Retrieved 12 June 2024.
  32. ^ Ratcliffe, Rebecca (22 July 2018). "Biker nun on a mission to free Tanzania from grip of HIV". The Guardian.
  33. ^ Nuki, Paul; Townsley, Simon (18 July 2018). "HIV and Aids in Africa has a new adversary – God and big pharma". The Telegraph.
  34. ^ Martelli, Giulia; Van Duffel, Lukas; Kwezi, Edith Cosmas; Cavallin, Francesco; Salehe, Idd Amiri; Torelli, Giovanni F.; Putoto, Giovanni; Hermans, Sabine; Rinke De Wit, Tobias F.; Pozniak, Anton (2022). "Community- and facility-based HIV testing interventions in northern Tanzania: Midterm results of Test & Treat Project". PLOS ONE. 17 (4): e0266870. Bibcode:2022PLoSO..1766870M. doi:10.1371/journal.pone.0266870. PMC 9004748. PMID 35413074.


Category:HIV/AIDS researchers Category:University of Michigan alumni Category:University of Colorado School of Medicine alumni Category:American scientists Category:Scientists from Maryland Category:21st-century scientists Category:Living people Category:Year of birth missing (living people) Category:American HIV/AIDS activists Category:American health activists